28,574 results found

The European Court of Justice recently held that a nonfertilized human ovum, the development of which has been stimulated by parthenogenesis should not be regarded as a human embryo within the meaning of the EU Biotech Directive.

Following the CMDh consensus position, EU Member States will begin revoking the marketing authorizations of these medicines in their territories according to an agreed timetable.

EFSA and the World Health Organization have published the draft conclusions and recommendations of their joint workshop on the Threshold of Toxicological Concern approach.

On February 9, 2015, EFSA launched a public consultation giving stakeholders and other interested parties the opportunity to comment on the draft update of its guidance for health claims related to gut and immune function.

The draft opinion proposes adequate intakes based on observed intakes in healthy populations in the EU.

It also details the kind of information and data applicants need to submit in support of their claim.

On October 23, 2015, the CHMP gave new advice for doctors and patients in order to minimize the risk of progressive multifocal leukoencephalopathy in patients treated with the multiple sclerosis medicine Tecfidera.

On January 6, 2015, certain health claims relating to glucose were rejected by Commission Regulation (EU) 2015/8 of 6 January 2015...

On October 6, 2015, the European Commission published frequently asked questions on the procedural aspects on establishing European Reference Networks.

The European Commission and the Scientific Committee on Emerging Newly Identified Health Risks have published guidance on determining potential health effects of using nanomaterials in medical devices.

On March 31, 2015, the European Commission issued Commission Regulation (EU) 2015/539 authorizing the following health claim...

The aim of the new working arrangement is to strengthen communication between the respective organizations and make it easier to take action to protect public health.

On March 9, 2015, the European Commission issued Commission Regulation (EU) 2015/391 of March 9, 2015, refusing to authorize certain health claims made on foods and referring to children's development and health.

On March 11, 2015, the European Commission issued Commission Regulation (EU) 2015/402 of 11 March 2015, refusing to authorize certain health claims made on foods...

The Bundesgerichtshof asked the Court of Justice whether the device may be classified as defective based solely on evidence that quality control checks on devices of the same model disclosed a potential defect.

On October 26, 2016, Members of European Parliament ("MEPs") resolved to place mandatory limits on industrially produced trans-fatty acids ("TFAs").

The European Federation of Pharmaceutical Industries and Associations and Innovative Medicines Initiative announced the launch of NewMeds new tool for avoiding duplicate enrollment of patients in clinical trials.

This development illustrates the medical device industry's focus on high ethical standards for industry–health care professional relationships.